BioDelivery Sciences International Inc (BDSI) Share Price Today, Stock Analysis, Annual Report | Value Research BioDelivery Sciences International Inc (BDSI) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

BioDelivery Sciences International Inc (BDSI)

Download Stock Report

NASDAQ: BDSI

  • Price Change
  • Market Capitalisation market-capitalisation-info $577 Mln

  • 12 Month Earnings monthly-earning $85 Mln
  • Price to Earnings price-to-earning 6.82

BioDelivery Sciences International Inc (BDSI) Share Price

$5.59

As on 31-Mar-2022 09:30 EDT

$0.000.00%

  • Prev Close info

    $5.59

  • Day's Openinfo

    $5.59

  • Today's Highinfo

    $5.59

  • Today's Lowinfo

    $5.59

  • Today's Volumeinfo

    --

Please wait...

BioDelivery Sciences International Inc (BDSI) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
BioDelivery Sciences International Inc (BDSI)
80.32 0.72 81.49 49.07 1.79 24.42 8.73
S&P BSE Sensex*
8.52 1.18 4.83 13.64 21.78 12.71 12.73
S&P BSE Healthcare#
20.70 -0.35 11.63 21.21 13.61 12.88 11.60
As on 31-Mar-2022  |  *As on 25-Sep-2023  |  #As on 25-Sep-2023
2021
2020
2019
2018
2017
2016
2015
BioDelivery Sciences International Inc (BDSI)
-26.19 -33.54 70.81 25.27 68.57 -63.47 -60.15
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

BioDelivery Sciences International Inc (BDSI) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of BioDelivery Sciences International Inc (BDSI)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        CEO & Director

        Mr. Jeffrey Allen Bailey

        Pres & Chief Commercial Officer

        Mr. Scott M. Plesha

        Headquarters

        Raleigh, NC

        FAQs for BioDelivery Sciences International Inc (BDSI)

        The total asset value of BioDelivery Sciences International Inc (BDSI) stood at $ 325 Mln as on 31-Dec-21

        The share price of BioDelivery Sciences International Inc (BDSI) is $5.590000 (NASDAQ) as of 31-Mar-2022 09:30 EDT. BioDelivery Sciences International Inc (BDSI) has given a return of 1.79% in the last 3 years.

        BioDelivery Sciences International Inc (BDSI) has a market capitalisation of $ 577 Mln as on 31-Mar-2022. As per Value Research classification, it is a company.

        The P/E (price to earnings) ratio of BioDelivery Sciences International Inc (BDSI) is 6.82 times as on 31-Mar-2022.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the BioDelivery Sciences International Inc (BDSI) and enter the required number of quantities and click on buy to purchase the shares of BioDelivery Sciences International Inc (BDSI).

        BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

        The CEO & director of Mr. Jeffrey Allen Bailey. is BioDelivery Sciences International Inc (BDSI), and CFO & Sr. VP is Mr. Scott M. Plesha.

        The promoters of BioDelivery Sciences International Inc (BDSI) have pledged 0% of the total equity as on Feb-22.

        BioDelivery Sciences International Inc (BDSI) Ratios
        Return on equity(%)
        57.33
        Return on capital employed(%)
        44.77
        Debt-to-equity ratio
        0.02
        Dividend yield(%)
        --

        Yes, TTM profit after tax of BioDelivery Sciences International Inc (BDSI) was $85 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $577.05 Mln
        • Revenue (TTM)revenue-information $84.17 Mln
        • Earnings (TTM) earning-information $84.86 Mln
        • Cash date-information $114.31 Mln
        • Total Debt info $4.62 Mln
        • Insider's Holding 7.58%
        • Liquidity liquidity
        • 52 Week range week-range $-- - --
        • Shares outstanding share-outstanding 103,229,000
        • 10 Years Aggregate:

          CFO: $-113.94 Mln

          EBITDA: $-124.69 Mln

          Net Profit: $-148.09 Mln

        About The Company

        • IPO Date 25-Jul-2002
        • CEO & Director Mr. Jeffrey Allen Bailey
        • Pres & Chief Commercial Officer Mr. Scott M. Plesha
        • Listing key-listing NASDAQ: BDSI
        • Country United States
        • Headquarters headquarters Raleigh, NC
        • Website website https://www.bdsi.com
        • Business

          BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its...  products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon